Related by context. All words. (Click for frequent words.) 77 oxycodone CR 76 receiving VICTRELIS 76 comparator arm 75 achieved ACR# 75 lopinavir r arm 75 5-FU/LV 75 FOLFOX4 75 mcg kg REBETOL 74 FOLFOX4 alone 74 Fludara 74 FOLFIRI alone 74 clodronate 74 plus dexamethasone 74 CYPHER Stent 74 pegylated interferon alfa 2b 74 lopinavir r 74 chlorambucil 73 relapsed MM 73 ACTEMRA TM 73 infusional 5-FU/LV 73 pegylated liposomal doxorubicin 73 Peg IFN 73 FluCAM arm 73 mitoxantrone plus 73 KRAS mutations occur 73 Zometa hazard 73 Flu Cy 73 low dose Iluvien 73 oral allopurinol 73 rimonabant #mg 72 8mg/kg 72 mcg QD 72 mcg albinterferon alfa 2b 72 plus methotrexate 72 Doxil ® 72 ritonavir boosted atazanavir 72 pegylated interferon alpha 72 adalimumab Humira 72 infliximab monotherapy 72 #mg BID [001] 71 docetaxel prednisone 71 Folfox 71 FluCAM 71 FOLFIRI 71 interferon ribavirin 71 LEXIVA r 71 plus prednisone 71 certolizumab 71 FOLFOX 71 rosuvastatin #mg 71 lamivudine monotherapy 71 recurrent glioblastoma multiforme 71 PASI scores 71 carboplatin paclitaxel 71 VELCADE melphalan 71 adjunctive placebo 71 Pegasys peginterferon alfa 2a 71 Viread Emtriva Sustiva 71 HBeAg negative patients 70 FOLFOX6 70 achieved sustained virologic 70 dacarbazine chemotherapy 70 mycophenolate mofetil 70 interferon alfa 2a 70 stage IIIb IV 70 postoperative chemotherapy 70 underwent surgical resection 70 receiving highly emetogenic 70 Hycamtin ® 70 peginterferon alfa 2a Pegasys 70 lenalidomide dexamethasone 70 iniparib BSI 70 ARCALYST ® 70 mcg Albuferon 70 oral diclofenac 70 imipenem 70 azathioprine 70 Navelbine 70 amoxicillin clavulanate 70 plus gemcitabine 70 IFN alfa 70 mg ustekinumab 70 Engerix B 70 APTIVUS r 70 telaprevir dosed 70 alfa 2a 70 TMC# r 70 receiving PEGINTRON 70 DOXIL 70 abacavir lamivudine 70 doxazosin 70 adriamycin 70 anthracycline taxane 70 ARB telmisartan 70 mg Lucentis 70 octreotide LAR 69 PREZISTA ritonavir 69 BARACLUDE ® 69 partial remissions 69 dacarbazine 69 XELOX 69 Pegintron 69 doxorubicin cyclophosphamide 69 cabazitaxel 69 PREZISTA r 69 peginterferon alfa 2a 69 NATRECOR R 69 receiving INTRON 69 receiving prophylactic anticoagulation 69 carboplatin chemotherapy 69 TMP SMX 69 salmeterol fluticasone 69 Aptivus ® 69 ELOXATIN 69 mitoxantrone 69 docetaxel chemotherapy 69 mcg doses 69 4mg/kg 69 CANCIDAS 69 aldosterone antagonist 69 melphalan prednisone 69 CIMZIA ™ 69 Viread Emtriva 69 chemoradiation therapy 69 nicardipine 69 splenectomized 69 preoperative chemotherapy 69 squamous histology 69 LPV r 69 evaluable subjects 69 mg BID 69 achieved CCyR 69 standard chemotherapy regimen 69 nadolol 69 metastatic GIST 68 prednisone prednisolone 68 tenofovir emtricitabine 68 CR nPR 68 aspirin clopidogrel 68 capecitabine Xeloda 68 Hazard Ratio 68 HBeAg positive patients 68 RLAI 68 low dose cytarabine 68 active comparator 68 Median PFS 68 achieved PASI 68 RGT arm 68 achieved sustained virological 68 peginterferon 68 Jevtana 68 iniparib 68 tamsulosin 68 definite stent thrombosis 68 ritonavir boosted 68 dalteparin 68 generalized edema 68 cyclophosphamide doxorubicin vincristine 68 piperacillin tazobactam 68 PegIntron 68 fluorouracil 68 COMBIVIR 68 insulin detemir 68 vincristine doxorubicin 68 prednisone prednisolone plus 68 CsA 68 lenalidomide Revlimid R 68 plus OBT 68 ALT flares 68 patients evaluable 68 FROVA 68 discontinuations due 68 mcg BID 68 tipranavir r 68 IFL chemotherapy regimen 68 severe exacerbations 68 #mg/day [001] 68 HBeAg seroconversion 68 ribavirin therapy 68 CIMZIA TM 68 3mg/kg 68 intravenous bisphosphonates 68 mg QD 68 pamidronate 68 daunorubicin 68 oxycodone IR 68 zolmitriptan 68 ritonavir boosted lopinavir 68 Taxotere ® 68 peginterferon alfa 2b 67 alpha interferons 67 #mg BID [003] 67 experienced virologic failure 67 docetaxel Taxotere 67 PEGINTRON TM 67 leukopenia 67 efavirenz EFV 67 CCyR 67 oral clodronate 67 systemic corticosteroid 67 methotrexate monotherapy 67 mRCC 67 APTIVUS R 67 placebo PBO 67 Thal Dex 67 recurrent GBM 67 HBeAg negative 67 QTcF 67 trastuzumab Herceptin R 67 Operative mortality 67 FUSILEV enhances 67 CHOP chemotherapy 67 metastatic renal cell carcinoma 67 tipranavir ritonavir 67 FOLFIRINOX 67 dose cytarabine 67 plus prednisone prednisolone 67 mCRC acneform rash 67 saline placebo 67 TEAEs 67 cyclophosphamide methotrexate 67 REVLIMID ® 67 CIMZIA TM certolizumab pegol 67 highly emetogenic 67 gemcitabine carboplatin 67 diarrhea nausea fatigue 67 protease inhibitor PI 67 thalidomide Thalomid 67 biologic DMARD 67 receiving ISENTRESS 67 cisplatin gemcitabine 67 Aloxi injection 67 % CI #.#-#.# [003] 67 ATACAND 67 folinic acid 67 pegylated interferon alfa 67 nodular partial response 67 #.#/#.# mmHg [001] 67 mg kg dose 67 complete cytogenetic response 67 adjunctive ABILIFY 67 CLL SLL 67 Elitek 67 idraparinux 67 tirofiban 67 micafungin 67 undetectable HBV DNA 67 evaluating tivozanib 67 tamoxifen Nolvadex ® 67 microbiological eradication 67 basiliximab 67 zidovudine lamivudine 67 paclitaxel cisplatin 67 fatigue asthenia 67 Navelbine ® 67 Peginterferon alfa 2b 67 binary restenosis 67 flutamide 67 nadroparin 67 eribulin 67 plus aztreonam 67 clopidogrel Plavix 67 doxorubicin docetaxel 67 Pemetrexed 67 splenectomized patients 67 decitabine 67 FOLPI 67 gemcitabine cisplatin 67 ULORIC 67 Camptosar ® 67 underwent CABG 67 alemtuzumab treated 67 Proleukin 67 cisplatin chemotherapy 67 temsirolimus 67 Velcade bortezomib 67 oblimersen 67 Copegus ribavirin 67 unfractionated heparin UFH 66 mcg linaclotide 66 sustained virologic response 66 oral Hycamtin 66 atorvastatin #mg 66 dexamethasone Decadron 66 AVONEX ® 66 atazanavir ritonavir 66 corticosteroid dose 66 degarelix 66 verum acupuncture 66 ribavirin RBV 66 Xeloda ® 66 5FU 66 pooled comparator 66 Lucentis monotherapy 66 mg/m2 dose 66 chemoradiotherapy 66 steroid dexamethasone 66 5-fluorouracil/leucovorin 66 irbesartan 66 ethambutol 66 DOXIL ® 66 lamivudine refractory patients 66 biochemical relapse 66 pCR 66 AZT zidovudine Retrovir 66 #mg q8h 66 morphometric vertebral fractures 66 p = NS 66 NMIBC 66 dose dexamethasone 66 tapentadol IR 66 ALND 66 BEACOPP 66 #Gy 66 chemoradiation 66 interferon alfa 66 titrated glipizide 66 Paraplatin ® 66 hip BMD 66 PEG Intron 66 Amrubicin 66 REYATAZ r arm 66 -#.# log# 66 Pred Forte 66 cyclophosphamide chemotherapy 66 Mg Uk 66 #mg doses [002] 66 lumbar spine BMD 66 teriflunomide 66 Pegasys ® 66 moderate renal impairment 66 antiandrogen 66 pegIFN 66 PSA nadir 66 argatroban 66 median PFS 66 lipid lowering agents 66 azacitidine 66 pegylated interferon alpha 2a 66 nondiabetic patients 66 EDSS scores 66 relapsed refractory multiple myeloma 66 fluticasone salmeterol 66 endoscopic remission 66 plus 5-FU/LV 66 Angiomax monotherapy 66 GnRH agonist 66 MCyR 66 REYATAZ R 66 achieved mucosal healing 66 Alkeran 66 Irinotecan 66 somatostatin analog 66 log# IU mL 66 divalproex sodium 66 ximelagatran 66 oxaliplatin Eloxatin 66 advanced adenomas 66 mitoxantrone chemotherapy 66 PEG INTRON R 66 HUMIRA achieved PASI 66 stavudine d4T 66 ONGLYZA saxagliptin 66 bezafibrate 66 doripenem 66 interferon alfa 2b 66 thiazide diuretic 66 TDF FTC 66 CR CRu 66 adalimumab 66 PREZISTA r arm 66 comparator PI r 66 achieving PASI 66 mg RDEA# 66 rizatriptan 66 Infusion reactions 65 methotrexate MTX 65 levosimendan 65 TNF antagonist 65 GnRH agonists 65 statin monotherapy 65 adjuvant radiotherapy 65 REMICADE monotherapy 65 oral hypoglycemic agent 65 primary hypercholesterolemia 65 adefovir 65 desvenlafaxine succinate 65 biphasic insulin aspart 65 alpha 2a 65 chronic angina 65 mg TID 65 PREZISTA rtv 65 complete cytogenetic 65 tapentadol ER 65 paclitaxel Taxol ® 65 dacarbazine DTIC 65 lispro 65 Gemzar ® 65 virologic failure 65 Vfend 65 FIRMAGON 65 Eloxatin R 65 hematologic toxicity 65 plus MTX 65 rFSH 65 Taxus Stent 65 #mg QD [001] 65 VaD 65 mg m² 65 sunitinib malate 65 sorafenib tablets 65 anthracyclines taxanes 65 HBeAg positive 65 EXJADE 65 chemotherapy cisplatin 65 mg simvastatin 65 serum urate 65 relapsed myeloma 65 gemcitabine chemotherapy 65 neoadjuvant radiation 65 PegIFN RBV 65 bendamustine 65 aminotransferase elevations greater 65 severe neutropenia 65 TAXUS Express Stent 65 Peginterferon 65 HCV RESPOND 2 65 Serious adverse reactions 65 baseline HbA1c 65 rFVIIa 65 Gemzar gemcitabine 65 Fludara ® 65 Raptiva r 65 sorafenib Nexavar 65 KRAS mutant tumors 65 NEUPOGEN 65 tocilizumab 65 #.#mg/dL 65 XIENCE V PROMUS Stent 65 deep venous thromboses 65 postintervention 65 placebo p = 65 hypophosphatemia 65 DMARDS 65 golimumab CNTO 65 cGy 65 goserelin 65 sirolimus eluting stent 65 cisplatin vinorelbine 65 trimethoprim sulfamethoxazole 65 interferon beta 1a 65 tacrolimus ointment 65 TORISEL 65 peginterferon alpha 2a 65 vandetanib 65 CAELYX 65 Femara letrozole 65 Gliadel Wafer 65 primary patency 65 ® lenalidomide 65 cytogenetic response 65 Free Survival PFS 65 pegylated interferon alfa 2a 65 annualized relapse 65 virologic breakthrough 65 tenecteplase 65 galiximab 65 fluvastatin 65 candesartan cilexetil 65 weekly CSBMs 65 ug dose 65 benazepril 65 DMARDs 65 peripheral sensory neuropathy 65 macrolide antibiotic 65 preintervention 65 Pegasys plus Copegus 65 prior chemotherapy regimens 65 Gemcitabine 65 urate lowering therapy 65 naïve HCV 65 unresectable stage 65 patients undergoing CABG 65 CALGB # [002] 65 del 5q MDS 65 ticlopidine 65 hepatic metastases 65 olmesartan 65 VFEND 65 tolterodine ER 65 baseline A1C 65 corticosteroid therapy 65 stage IIIB 65 unfractionated heparin 65 idarubicin 65 febrile neutropenia 65 sirolimus stent 65 relapsed multiple myeloma 65 unresectable HCC 65 salmeterol fluticasone propionate 65 alfuzosin 65 Median survival 65 ABVD 65 solifenacin 65 rectal tenesmus 65 5 fluorouracil leucovorin 65 fluoxetine paroxetine 65 glargine 65 arterial thromboembolic events 65 #mg/day [002] 65 enalapril 65 nevirapine Viramune 65 Torisel 65 μg dose 65 elevated serum creatinine 65 herpetic keratitis 65 angiographic outcomes 65 #mg QD [002] 65 ARCOXIA 65 anemia hemoglobin 65 etanercept 65 MabThera Rituxan 64 YERVOY 64 NATRECOR ® 64 Neulasta R 64 peg IFN 64 palifermin 64 elevated LDH 64 undetectable viral 64 relapsed CLL 64 potent CYP#A# inhibitors 64 bone marrow reticulin deposition 64 undergone splenectomy 64 metastatic renal cell 64 Mitoxantrone 64 levofloxacin 64 TNF antagonists 64 q#h 64 MACUGEN 64 trastuzumab Herceptin ® 64 tazobactam 64 hepatorenal syndrome 64 NPH insulin 64 erlotinib Tarceva ® 64 TEMODAL 64 REYATAZ r 64 DMARD 64 irinotecan chemotherapy 64 cinacalcet 64 + PH# 64 eosinophilic asthma 64 Platinol ® cisplatin 64 Infusion Reactions Severe 64 Herceptin trastuzumab 64 PROCTOCORT ® Suppository Hydrocortisone 64 budesonide pMDI 64 revascularizations 64 ropivacaine 64 microalbumin test 64 vinorelbine 64 ertapenem 64 myelodysplastic myeloproliferative diseases 64 nonmelanoma skin cancers 64 mg qd 64 bicalutamide 64 ibandronate 64 PSADT 64 Cariprazine 64 Adjuvant chemotherapy 64 maximal doses 64 MGd 64 MACCE 64 NovoTTF 64 cytogenetic responses 64 MoxDuo TM IR 64 Filgrastim 64 MIRAPEX 64 darunavir r 64 PEGINTRON REBETOL groups 64 paclitaxel Taxol R 64 mL/min/#.# m 2 64 venlafaxine Effexor 64 metastatic CRC 64 5 FU leucovorin 64 terazosin 64 non splenectomized 64 mometasone furoate 64 Noxafil 64 Median progression 64 Paraplatin ® carboplatin 64 cytarabine daunorubicin 64 Campath alemtuzumab 64 interferon gamma 1b 64 dose colchicine 64 infusional 64 zonisamide SR 64 insulin glulisine 64 SCIg 64 gout flare 64 imiquimod cream 64 Mg Usa 64 cilostazol 64 oral rivaroxaban 64 evaluable patients 64 BCG refractory carcinoma 64 BRIM2 64 INTEGRILIN R 64 peginterferon alfa 64 invasive candidiasis 64 VIAject ™ 64 elotuzumab 64 q8h 64 receiving golimumab 64 refractory AML 64 anastrazole 64 caspofungin 64 fosamprenavir 64 MADRS score 64 β blocker 64 entecavir 64 Xelox 64 alteplase 64 mg BID dose 64 3TC lamivudine Epivir 64 RSR# efaproxiral 64 mcg kg 64 SUPPRELIN R LA 64 amprenavir 64 ceftazidime 64 TAXUS p value 64 undergone radical prostatectomy 64 perioperative mortality 64 pegylated interferon peg IFN 64 refractory CLL 64 MAGE A3 ASCI 64 pyrazinamide 64 NEVO 64 metastatic hormone refractory 64 Tipranavir 64 lamivudine 64 EBRT 64 indinavir 64 mapatumumab 64 TAXOTERE R 64 glycated hemoglobin HbA1c 64 TPV r 64 follicular lymphomas 64 Ishak fibrosis score 64 Cladribine tablets 64 #mg/m# [001] 64 intravitreal injections 64 timepoints 64 Apidra ® 64 telaprevir pegylated interferon 64 sulfasalazine 64 DMARD therapy 64 mg q#h 64 ZACTIMA 64 sumatriptan naproxen sodium 64 drotrecogin alfa activated 64 IOP lowering 64 HBeAg + 64 genotypic resistance 64 pT3 64 sorafenib Nexavar ® 64 locoregional recurrence 64 Ceplene/IL-2 64 recurrent VTE 64 HbA 1c levels 64 mg Proellex 64 DAS# CRP 64 advanced hepatocellular carcinoma 64 oral antidiabetes 64 lung metastases 64 REMICADE ® 64 % CI #.#-#.# [007] 64 log# copies mL 64 underwent resection 64 neoadjuvant therapy 64 Thalomid ® 64 metastatic malignant 64 postmenopausal osteoporotic women 64 oral antidiabetic medication 64 Zorbtive TM 64 AGILECT R 64 autoantibody positive 64 iodixanol 64 non valvular atrial 64 placebo fluoxetine 64 chemotherapy gemcitabine 64 leukemia AML 64 Nexavar sorafenib 64 Ixempra 64 oral vancomycin 64 plus GP IIb 64 mutated KRAS 63 leukemia APL 63 ALT elevation 63 Taxotere docetaxel 63 metastatic RCC 63 febuxostat 63 paroxetine Paxil 63 rimonabant #mg/day 63 liposomal doxorubicin 63 posaconazole 63 pegylated interferon 63 lipid lowering therapy 63 TAVR 63 ABC/3TC 63 PEG Interferon alfa 63 brand ciclesonide HFA 63 parecoxib 63 concomitant antibiotics 63 dose melphalan 63 decompensated liver disease 63 nasopharyngitis 63 Betaferon R 63 -#.# log# copies mL 63 PENTASA 63 efavirenz emtricitabine 63 hypokalemia 63 CIN3 63 paclitaxel carboplatin 63 imiquimod 63 Pegylated Interferon 63 heavily pretreated 63 plus COPEGUS 63 microgram kg 63 doxorubicin HCl liposome injection 63 ACR# responses 63 antiretroviral naïve 63 sustained virological response 63 COPEGUS ribavirin 63 INCB# [003] 63 Temodar ® 63 infliximab 63 mg eq 63 enoxaparin 63 esophageal candidiasis 63 operable pancreatic cancer 63 ezetimibe simvastatin 63 deferoxamine 63 Platelet counts 63 pomalidomide 63 NEVO ™ 63 Kivexa 63 nonsignificant difference 63 radical nephrectomy 63 Lantus ® 63 haematologic 63 gemcitabine Gemzar 63 R adefovir dipivoxil 63 SPRYCEL ® 63 dizziness nausea diarrhea 63 cetuximab Erbitux R 63 Aflibercept 63 #mg dose [003] 63 Roche Pegasys 63 Newly Diagnosed Multiple Myeloma 63 transaminase elevations 63 neutropenia dehydration dyspnea 63 laparoscopically assisted 63 Tumors shrank 63 BENICAR HCT 63 metoprolol tartrate 63 pyridostigmine 63 Viread Emtriva SUSTIVA 63 #.#g/day 63 reteplase 63 estramustine 63 humanized interleukin 6 63 lopinavir ritonavir Kaletra 63 cefuroxime 63 concurrent chemoradiation 63 colorectal liver metastases 63 aprepitant 63 evaluable 63 tinidazole 63 metformin monotherapy 63 ZOLINZA 63 severe renal impairment 63 BUPHENYL R sodium phenylbutyrate 63 tolvaptan 63 quetiapine risperidone 63 baseline LDH 63 bupropion SR 63 custirsen 63 saquinavir ritonavir 63 VIRAMUNE 63 ziprasidone 63 LUCENTIS 63 Zevalin R Ibritumomab 63 Doxil 63 Naive Patients 63 rufinamide 63 ORENCIA ® 63 etanercept Enbrel 63 moderately emetogenic 63 topotecan 63 median survivals 63 adjuvant radiation 63 debulking surgery 63 refractory chronic lymphocytic 63 reinfarction 63 subcutaneous enoxaparin 63 elevated alkaline phosphatase 63 TURBT 63 zoledronic acid 63 sargramostim 63 #mg ATC 63 5 Fluorouracil 63 Tarceva erlotinib 63 paclitaxel chemotherapy 63 PRADAXA #mg 63 mCRC patients 63 darunavir ritonavir 63 conjunctival hyperemia 63 receiving VELCADE 63 azacytidine 63 prostate TURP 63 standard chemotherapy regimens 63 Sandostatin R 63 rituximab Rituxan 63 sham injections 63 aflibercept VEGF Trap 63 metastatic lung cancer 63 urinary N telopeptide 63 alkylating agent 63 dapagliflozin plus 63 calcineurin inhibitor 63 clinically evaluable patients 63 Nonresidential structures 63 elevated ALT 63 gp# vaccine 63 relapsing remitting MS RRMS 63 rosuvastatin Crestor 63 Hycamtin 63 mycophenolic acid 63 Acetate Rectal Suppositories 63 nilotinib 63 intravesical infusion therapy 63 endocrine therapies 63 valacyclovir 63 BRAF inhibitor 63 concomitant AEDs 63 abatacept 63 Ovitrelle R Serostim 63 weekly subcutaneous injections 63 TAXUS Liberte Long 63 FEMALES SHOULD BE ADVISED 63 angiotensin converting enzyme inhibitor 63 AEGR 63 pegaptanib 63 betamethasone dipropionate #.# 63 BRCA1 mutation carriers 63 symptomatic aortic stenosis 63 neutrophil counts 63 & s2 = 63 beta blocker atenolol 63 stage IIIB IV 63 visilizumab 63 locoregional 63 Epivir 63 nonmetastatic 63 inhaled treprostinil 63 PEG INTRON 63 FAMPYRA 63 dose dabigatran 63 aspirin heparin 63 everolimus eluting stents 63 serum clusterin levels 63 Decitabine 63 NSTE ACS 63 AVODART 63 thromboembolic events 63 baminercept 63 unresectable tumors 63 stage IIIb 63 metastatic carcinoid 63 TTF Therapy 63 R rilonacept Injection 63 mg administered orally 63 RAPAFLO R 63 Kepivance 63 follicular lymphoma FL 63 symptomatic BPH 63 pyrexia mucositis sepsis febrile 63 VIDAZA 63 Increlex R 63 Sandostatin 63 baseline Hb 63 methotrexate therapy 63 Dementia Related Psychosis 63 echinacea tablets 63 Capecitabine 63 Taxol paclitaxel 63 paricalcitol 63 relapsing multiple sclerosis 63 adjuvant tamoxifen 63 severe hypoglycemic 63 evaluating REVLIMID 63 asymptomatic carotid stenosis 63 budesonide foam 63 BoNTA 63 BENICAR 63 hepatitis C genotype 63 #mg dosing group 63 TACE 62 leuprorelin 62 IV NSCLC 62 boosted protease inhibitor 62 paliperidone ER 62 daily subcutaneous injections 62 VcMP 62 Proellex TM 62 IXEMPRA 62 Virologic 62 RRMS patients 62 mL/min/#.# m2 62 subependymal giant cell 62 exemestane 62 mm Stent 62 abacavir Ziagen 62 intravenous RSD# 62 Natalizumab 62 fluorouracil leucovorin 62 dasatinib 62 XIENCE V demonstrated 62 DAPT 62 letrozole Femara 62 #mg dose [002] 62 nonsmall cell lung cancer 62 pemetrexed 62 Platinol ® 62 levetiracetam 62 adefovir treated 62 postoperative inflammation 62 #mg #mg #mg [003] 62 glycated hemoglobin levels 62 mCi kg 62 IFN α 62 ACR# response 62 Cypher Stent 62 subcutaneously administered 62 basal bolus regimen 62 Durezol 62 sUA 62 symptomatic VTE 62 ZOMIG Nasal Spray 62 oral FTY# 62 glycoprotein IIb IIIa inhibitor 62 nab paclitaxel 62 ALA PDT 62 mg hydrochlorothiazide 62 abnormal p# biomarker 62 tenofovir FTC 62 elevated transaminases 62 free survival PFS 62 INC# 62 ug kg 62 eplerenone 62 low dose dexamethasone 62 verteporfin 62 sunitinib Sutent 62 tipranavir 62 interferon ribavirin combination 62 AVELOX 62 docetaxel Taxotere R 62 CYT# potent vascular disrupting 62 ACTEMRA 62 angiographic restenosis 62 Pegylated interferon 62 abiraterone acetate 62 efavirenz Sustiva 62 candesartan 62 oral olanzapine 62 inhaled budesonide 62 Celsentri Selzentry 62 dasatinib Sprycel ® 62 histologically confirmed 62 paclitaxel eluting stents 62 romiplostim 62 docetaxel prednisone alone 62 epirubicin cyclophosphamide 62 microbiologically evaluable 62 zoledronate 62 pegylated interferon ribavirin 62 AA Amyloidosis 62 recurrent genital herpes 62 intravenous cyclophosphamide 62 ARIXTRA 62 alanine transaminase ALT 62 weekly intravenous infusions 62 tigecycline 62 triamcinolone 62 voriconazole 62 neoadjuvant chemotherapy 62 ARIMIDEX 62 RECORD1